NCT04060316View on ClinicalTrials.gov

GLS-1200 Topical Nasal Spray to Prevent Sinusitis After Endoscopic Sinus Surgery

PHASE2UnknownINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

September 30, 2024

Conditions
Sinusitis Chronic
Interventions
DRUG

GLS-1200

GLS-1200 is given as a nasal spray using an atomizer

DRUG

Placebo

Placebo is given as a nasal spray using an atomizer

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

Sponsors
All Listed Sponsors
lead

GeneOne Life Science, Inc.

INDUSTRY

NCT04060316 - GLS-1200 Topical Nasal Spray to Prevent Sinusitis After Endoscopic Sinus Surgery | Biotech Hunter | Biotech Hunter